Back to Blog & Insights

Member Feature

Kelly McCorkell Builds the Operational Foundation for Cell and Gene Therapy

Through Arbor CGT Partners, biomedical scientist and laboratory operations leader Kelly McCorkell helps emerging cell and gene therapy teams build the equipment, documentation, training, and laboratory systems needed to advance their science.

Portrait of biomedical scientist and Arbor CGT Partners Co-Founder Kelly McCorkell

Promising cell and gene therapy programs require more than compelling science. They also need equipment, trained teams, clear documentation, functional laboratory space, and operating systems that can support increasingly complex work. Kelly McCorkell has spent more than 25 years working where those scientific and operational demands meet.

Now Co-Founder of Arbor CGT Partners, LLC, Kelly helps life-science and cell and gene therapy organizations move from early research toward scalable, clinical-grade operations. The Philadelphia firm, formed in June 2026, also works with the facilities that house emerging companies. Its services include laboratory assessments, tenant onboarding, equipment and documentation planning, training, laboratory design, and ongoing laboratory management consulting.

Building operations alongside the science

Arbor CGT Partners is grounded in a challenge Kelly has observed throughout her career: an innovative program can encounter obstacles when its operational foundation does not develop alongside its science. A team may be advancing its research while still needing to determine how laboratory space should function, what equipment is appropriate, how procedures will be documented, or how personnel will be trained.

Addressing those needs early can give scientific teams a clearer path as their work grows more complex. Kelly’s focus is practical: helping organizations understand their current laboratory capabilities, identify gaps, and establish systems suited to their next stage. For innovation facilities and their tenants, that can also mean creating an onboarding and management structure that supports multiple teams without losing sight of laboratory requirements.

From experimental questions to laboratory leadership

Kelly’s approach began at the bench. Her scientific training includes a PhD in Genetics, Genomics and Cancer Biology, followed by academic research and a progression from postdoctoral work to senior research responsibilities. That background gave her a foundation in examining biological questions and working carefully with complex evidence.

Alongside her research, she taught undergraduate biology as an adjunct faculty member. Research and teaching required her to examine complex questions closely, communicate technical ideas clearly, and connect individual experiments to broader biological systems.

Her transition into operational leadership did not mean stepping away from laboratory work. She moved into regulated laboratory operations and team leadership, expanding her perspective from conducting research to creating the conditions in which technical teams could perform consistent, regulated work. That progression linked scientific understanding with the practical organization of people, equipment, and procedures.

Supporting cellular therapy programs

Her later leadership work included clinical cellular therapy laboratories, where responsibilities spanned team coordination, laboratory readiness, and the operational support needed around emerging treatments. Working in these settings broadened her understanding of how scientific programs depend on reliable systems and collaboration across professional disciplines.

Experience across cell and gene therapy settings reinforced the importance of documentation, training, workflow, and laboratory capacity. These are practical concerns that connect the science to the environment in which it is carried out. Kelly brings that perspective to helping teams assess the operational foundations they need as their work develops.

Her background also includes regulated biorepository operations. Across these different laboratory environments, she has developed a perspective that links quality systems and operational planning with the day-to-day work of scientific and technical teams.

Leadership that remains close to the laboratory

Across research, cryobanking, cellular therapy, and biorepository operations, Kelly has remained personally hands-on in the laboratory. That continuity shapes her leadership: operational decisions stay connected to how scientists and technical staff actually perform their work.

It also informs a broader message for women in science. Operations and leadership can offer a path to wider responsibility without requiring scientists to abandon their technical grounding. Kelly’s career shows how scientific training can become a foundation for designing laboratories, guiding teams, and building systems around emerging therapies.

Through Arbor CGT Partners, she is bringing those strands together. Her work centers on a straightforward but consequential idea: for promising science to advance, the operational foundation must be ready to advance with it.